Exploring the ability of vocal biomarkers in distinguishing depression from bipolar disorder, schizophrenia, and healthy controls

被引:3
|
作者
Pan, Wei [1 ,2 ,3 ]
Deng, Fusong [4 ]
Wang, Xianbin [1 ,2 ,3 ]
Hang, Bowen [1 ,2 ,3 ]
Zhou, Wenwei [1 ,2 ,3 ]
Zhu, Tingshao [5 ,6 ]
机构
[1] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China
[2] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China
[3] Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China
[4] Wuhan Univ Sci & Technol, Wuhan Wuchang Hosp, Wuchang Hosp, Wuhan, Peoples R China
[5] Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China
[6] Chinese Acad Sci, Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
depression; healthy controls; schizophrenia; bipolar disorder; i-vectors; logistic regression MFCCs; SPEECH EMOTION RECOGNITION; NEGATIVE SYMPTOMS; MATCHING METHODS; FEATURES; PERFORMANCE; EXPRESSION; DISEASES; PROSODY; MODELS;
D O I
10.3389/fpsyt.2023.1079448
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundVocal features have been exploited to distinguish depression from healthy controls. While there have been some claims for success, the degree to which changes in vocal features are specific to depression has not been systematically studied. Hence, we examined the performances of vocal features in differentiating depression from bipolar disorder (BD), schizophrenia and healthy controls, as well as pairwise classifications for the three disorders. MethodsWe sampled 32 bipolar disorder patients, 106 depression patients, 114 healthy controls, and 20 schizophrenia patients. We extracted i-vectors from Mel-frequency cepstrum coefficients (MFCCs), and built logistic regression models with ridge regularization and 5-fold cross-validation on the training set, then applied models to the test set. There were seven classification tasks: any disorder versus healthy controls; depression versus healthy controls; BD versus healthy controls; schizophrenia versus healthy controls; depression versus BD; depression versus schizophrenia; BD versus schizophrenia. ResultsThe area under curve (AUC) score for classifying depression and bipolar disorder was 0.5 (F-score = 0.44). For other comparisons, the AUC scores ranged from 0.75 to 0.92, and the F-scores ranged from 0.73 to 0.91. The model performance (AUC) of classifying depression and bipolar disorder was significantly worse than that of classifying bipolar disorder and schizophrenia (corrected p < 0.05). While there were no significant differences in the remaining pairwise comparisons of the 7 classification tasks. ConclusionVocal features showed discriminatory potential in classifying depression and the healthy controls, as well as between depression and other mental disorders. Future research should systematically examine the mechanisms of voice features in distinguishing depression with other mental disorders and develop more sophisticated machine learning models so that voice can assist clinical diagnosis better.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Minor physical anomalies in bipolar disorder in comparison to healthy controls and schizophrenia: A systematic review and meta-analysis
    Bora, Emre
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 65 : 4 - 11
  • [42] Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls
    Bora, Emre
    Pantelis, Christos
    SCHIZOPHRENIA BULLETIN, 2015, 41 (05) : 1095 - 1104
  • [43] Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder
    Costa, Alana C.
    Rica, Larissa B.
    van de Bilt, Martinus
    Zandonadi, Flavia S.
    Gattaz, Wagner F.
    Talib, Leda L.
    Sussulini, Alessandra
    METABOLITES, 2023, 13 (05)
  • [44] Schizophrenia and depression:: Challenging the paradigm of two separate diseases -: A controlled study of schizophrenia, depression and healthy controls
    Häfner, H
    Maurer, K
    Trendler, G
    an der Heiden, W
    Schmidt, M
    Könnecke, R
    SCHIZOPHRENIA RESEARCH, 2005, 77 (01) : 11 - 24
  • [45] Pharmacotherapy of Suicidal Behaviour in Major Depression, Schizophrenia and Bipolar Disorder
    Filakovic, Pavo
    Eric, Anamarija Petek
    COLLEGIUM ANTROPOLOGICUM, 2013, 37 (03) : 1039 - 1044
  • [46] Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia
    Cotter, D
    Hudson, L
    Landau, S
    BIPOLAR DISORDERS, 2005, 7 (04) : 358 - 369
  • [47] Analysis of ependymal abnormalities in subjects with schizophrenia, bipolar disorder, and depression
    Gilmore, JH
    Bouldin, TW
    SCHIZOPHRENIA RESEARCH, 2002, 57 (2-3) : 267 - 271
  • [48] Classification of Patients with Bipolar Disorder and Their Healthy Siblings from Healthy Controls Using MRI
    Cigdem, Ozkan
    Horuz, Erencan
    Soyak, Refik
    Aydeniz, Burhan
    Sulucay, Aysu
    Oguz, Kaya
    Demire, Hasan
    Kitis, Omer
    Eker, Cagdas
    Gonul, Ali Saffet
    Unay, Devrim
    2019 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND APPLICATIONS (MEMEA), 2019,
  • [49] Digital Communication Biomarkers of Mood and Diagnosis in Borderline Personality Disorder, Bipolar Disorder, and Healthy Control Populations
    Gillett, George
    McGowan, Niall M.
    Palmius, Niclas
    Bilderbeck, Amy C.
    Goodwin, Guy M.
    Saunders, Kate E. A.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [50] Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
    Rolstad, Sindre
    Jakobsson, Joel
    Sellgren, Carl
    Ekman, Carl-Johan
    Blennow, Kaj
    Zetterberg, Henrik
    Palsson, Erik
    Landen, Mikael
    PLOS ONE, 2015, 10 (05):